Monitoring serum vancomycin concentrations in children : Is it necessary?

[1]  W. Leader,et al.  Pharmacokinetic Optimisation of Vancomycin Therapy , 1995, Clinical pharmacokinetics.

[2]  N. Saunders.  Why monitor peak vancomycin concentrations? , 1994, The Lancet.

[3]  M. Malogolowkin,et al.  A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. , 1994, The Pediatric infectious disease journal.

[4]  R. Moellering.  Monitoring serum vancomycin levels: climbing the mountain because it is there? , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  P. Lietman,et al.  Serum vancomycin concentrations: reappraisal of their clinical value. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Wenzel,et al.  The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. , 1993, JAMA.

[7]  R. Polin,et al.  Vancomycin pharmacokinetics in infants: relationships to indices of maturation. , 1986, Pediatric infectious disease.

[8]  N. Fineberg,et al.  Effects of vancomycin on renal function in rats , 1981, Antimicrobial Agents and Chemotherapy.

[9]  G. Mccracken,et al.  Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.